Krystal Biotech (KRYS) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $2.66.
- Krystal Biotech's EPS (Weighted Average and Diluted) rose 19230.77% to $2.66 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.68, marking a year-over-year increase of 27528.09%. This contributed to the annual value of $3.0 for FY2024, which is 66870.48% up from last year.
- Krystal Biotech's EPS (Weighted Average and Diluted) amounted to $2.66 in Q3 2025, which was up 19230.77% from $1.29 recorded in Q2 2025.
- In the past 5 years, Krystal Biotech's EPS (Weighted Average and Diluted) registered a high of $2.79 during Q3 2023, and its lowest value of -$1.99 during Q1 2022.
- In the last 5 years, Krystal Biotech's EPS (Weighted Average and Diluted) had a median value of -$0.7 in 2021 and averaged -$0.02.
- As far as peak fluctuations go, Krystal Biotech's EPS (Weighted Average and Diluted) crashed by 16885.03% in 2022, and later skyrocketed by 390000.0% in 2025.
- Krystal Biotech's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.95 in 2021, then tumbled by 31.58% to -$1.25 in 2022, then skyrocketed by 124.8% to $0.31 in 2023, then soared by 393.67% to $1.53 in 2024, then soared by 73.81% to $2.66 in 2025.
- Its EPS (Weighted Average and Diluted) was $2.66 in Q3 2025, compared to $1.29 in Q2 2025 and $1.2 in Q1 2025.